Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Pathways in cancer | R-HSA-9824443 | map05200 | moracizine | 34633 | drug-path |
Pancreatic cancer | R-HSA-9700206 | map05212 | moracizine | 34633 | drug-path |
Prostate cancer | R-HSA-2990872 | map05215 | moracizine | 34633 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | moracizine | 34633 | drug-path |
Small cell lung cancer | R-HSA-5619066 | map05222 | moracizine | 34633 | drug-path |
ABC transporters | R-HSA-1369007 | map02010 | moracizine | 34633 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | rimexolone | 5311412 | drug-path |
Renin-angiotensin system | R-HSA-168256 | map04614 | rimexolone | 5311412 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | rimexolone | 5311412 | drug-path |
ErbB signaling pathway | R-HSA-168638 | map04012 | rimexolone | 5311412 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | rimexolone | 5311412 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | rimexolone | 5311412 | drug-path |
Glioma | Q9NZM4 | map05214 | rimexolone | 5311412 | drug-path |
Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | rimexolone | 5311412 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | rimexolone | 5311412 | drug-path |
Shigellosis | 0 | map05131 | rimexolone | 5311412 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | rimexolone | 5311412 | drug-path |
Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | rimexolone | 5311412 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | rimexolone | 5311412 | drug-path |
VEGF signaling pathway | R-HSA-194138 | map04370 | rimexolone | 5311412 | drug-path |